Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherko Kuemmel

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|March 23, 2019
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patientsNaiba Nabieva, Lothar Häberle, Sara Y Brucker, et al.
BMJ Open|September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trialElisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Cancer Treatment Reviews|May 1, 2023
Uncertainties and controversies in axillary management of patients with breast cancerWalter P Weber, Oreste Davide Gentilini, Monica Morrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerPatricia A Ganz, Hanna Bandos, Tanja Španić, et al.
JAMA Surgery|July 19, 2023
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast CancerWalter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Breast (Edinburgh, Scotland)|September 23, 2021
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2025
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
Breast Cancer Research and Treatment|June 24, 2023
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Christoph Tausch, Kavitha Däster, Stefanie Hayoz, et al.
JAMA Oncology|April 25, 2024
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyGiacomo Montagna, Mary M Mrdutt, Susie X Sun, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|March 23, 2019
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patientsNaiba Nabieva, Lothar Häberle, Sara Y Brucker, et al.
BMJ Open|September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trialElisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Cancer Treatment Reviews|May 1, 2023
Uncertainties and controversies in axillary management of patients with breast cancerWalter P Weber, Oreste Davide Gentilini, Monica Morrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerPatricia A Ganz, Hanna Bandos, Tanja Španić, et al.
JAMA Surgery|July 19, 2023
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast CancerWalter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Breast (Edinburgh, Scotland)|September 23, 2021
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2025
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
Breast Cancer Research and Treatment|June 24, 2023
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Christoph Tausch, Kavitha Däster, Stefanie Hayoz, et al.
JAMA Oncology|April 25, 2024
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyGiacomo Montagna, Mary M Mrdutt, Susie X Sun, et al.
Pageof 9